AU3765897A - Use of a plasminogen activator for the treatment of pulmonary disorders - Google Patents
Use of a plasminogen activator for the treatment of pulmonary disordersInfo
- Publication number
- AU3765897A AU3765897A AU37658/97A AU3765897A AU3765897A AU 3765897 A AU3765897 A AU 3765897A AU 37658/97 A AU37658/97 A AU 37658/97A AU 3765897 A AU3765897 A AU 3765897A AU 3765897 A AU3765897 A AU 3765897A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- plasminogen activator
- pulmonary disorders
- pulmonary
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A61K38/166—Streptokinase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK86296 | 1996-08-14 | ||
DK862/96 | 1996-08-14 | ||
PCT/DK1997/000330 WO1998006426A1 (en) | 1996-08-14 | 1997-08-14 | Use of a plasminogen activator for the treatment of pulmonary disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3765897A true AU3765897A (en) | 1998-03-06 |
Family
ID=8098378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU37658/97A Abandoned AU3765897A (en) | 1996-08-14 | 1997-08-14 | Use of a plasminogen activator for the treatment of pulmonary disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3765897A (en) |
WO (1) | WO1998006426A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105764488A (en) | 2013-11-04 | 2016-07-13 | 得克萨斯州大学系统董事会 | Compositions and methods for administration of enzyme to subject's airway |
WO2016179447A1 (en) * | 2015-05-06 | 2016-11-10 | Board Of Regents, The University Of Texas System | Compositions and methods for administration of an enzyme to a subject's airway |
US20230081922A1 (en) * | 2020-02-11 | 2023-03-16 | Talengen International Limited | Method and drug for treating viral pneumonia |
US20230146662A1 (en) | 2020-04-23 | 2023-05-11 | Previpharma Consulting Gmbh | Plasminogen for use in treating and preventing lung dysfunction |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4790305A (en) * | 1986-06-23 | 1988-12-13 | The Johns Hopkins University | Medication delivery system |
EP0363060B1 (en) * | 1988-10-04 | 1994-04-27 | The Johns Hopkins University | Aerosol inhaler |
EP0580685B1 (en) * | 1991-04-16 | 1996-01-03 | Roche Diagnostics GmbH | Pharmaceutical packaging unit containing plasminogen activators for multiple-bolus administration |
US5531219A (en) * | 1994-11-04 | 1996-07-02 | Alliance Pharmaceutical Corp. | Use of liquid fluorocarbons to facilitate pulmonary drug delivery |
-
1997
- 1997-08-14 WO PCT/DK1997/000330 patent/WO1998006426A1/en active Application Filing
- 1997-08-14 AU AU37658/97A patent/AU3765897A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998006426A1 (en) | 1998-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3339897A (en) | Sulphonamide derivatives and their use in the treatment of cns disorders | |
AU6396598A (en) | Arylsulphonamides and analogues and their use for the treatment and neurovegetative disorders | |
AU3201095A (en) | Substituted thiazoles for the treatment of inflammation | |
AU2805195A (en) | Therapeutic compounds | |
AU2058697A (en) | Treatment of sleep disorders | |
AU2424895A (en) | Substituted spirodienes for the treatment of inflammation | |
ZA979731B (en) | Treatment of asthma. | |
AU7310896A (en) | Use of nitroflavonoids for the treatment of anxiety | |
HK1022267A1 (en) | Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis | |
AU3765897A (en) | Use of a plasminogen activator for the treatment of pulmonary disorders | |
CZ20011872A3 (en) | Isonipecotamides for the treatment of integrin-mediated disorders | |
AU2547895A (en) | Therapeutic phenoxyalkylheterocycles | |
AU1853397A (en) | Treatment of pulmonary inflammation | |
AUPO118896A0 (en) | New use | |
AU2154695A (en) | Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof | |
GB9726223D0 (en) | The treatment of materials | |
AU1587295A (en) | The treatment of gaseous substances | |
AU8035098A (en) | Cephalosporin compounds, use thereof and intermediate compounds of the same | |
AU2713797A (en) | Depigmentating agent in the treatment of melasma | |
AU5330198A (en) | Therapeutic compounds | |
AU2671895A (en) | Bisquinolines for the treatment of malaria | |
AU1714195A (en) | Therapeutic benzonitriles | |
AU2973997A (en) | Use of substituted azaspirane in the treatment of asthma | |
AU8057194A (en) | Substituted 3-phenyl-1,2,3,4-oxatriazole-5-imines useful for the treatment of asthma and thrombosis | |
AUPM424794A0 (en) | Treatment of anorectal disorders |